The new Omicron Sub-Variant threat is spreading over the globe. It is a new coronavirus mutant that is easily transmitted to others and has a short incubation time. In a high-level meeting chaired by Prime Minister Narendra Modi on Thursday, December 22, 2022, the Indian government revised various instructions about Covid. Furthermore,according to the sources, the Union Health Ministry has approved Bharat Biotech's Intranasal Covid Vaccine for inclusion in the immunization programme as a booster dose for people above the age of 18. The vaccine will be available on CoWIN. 

The needle-free Bharat Biotech Intranasal Vaccine will be provided in medical centers. The Nasal Vaccine BBV154, a heterologous booster dose, has been certified by the Drugs Controller General of India for restricted use in an emergency situation for people above 18 years of age. 

Minister Jyotiraditya Scindia emphasized the current vaccination campaign against Covid-19 on Friday, December 23, 2023. Addressing a news conference on the BJP's efforts toward a ‘Healthy India,’ the Union Minister stated that 220 crore doses of vaccine had been administered. 

According to the Union Health Ministry, India recorded 163 new coronavirus infections, while active cases decreased to 3,380. The death toll now stands at 5,30,690, with nine people killed. The total number of covid cases is 4.46 crore (4,46,76,678). Kerala reconciled six fatalities, Maharashtra two, and Delhi one. Active cases account for 0.01 percent of overall infection, while the national Covid-19 recovery rate has risen to 98.80 percent in the last 24 hours. 

Despite the recent global spike in Covid cases caused by a new variation B.F7, the central administration has informed the public that the country's covid positive rate is decreasing week by week with only 0.14% positivity. Daily instances on average during the week ending of December 21, 2022, India contributed just 0.03% of all Covid cases recorded worldwide. According to Health Ministry data, India's worldwide contribution of just 153 cases is significantly lower than Japan's contribution of 1,54,521-26.8%.